BOTHELL, Wash.--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing therapies for blinding eye diseases, today announced that Ryo Kubota, M.D., Ph.D., Acucela’s chief executive officer, will present next week at the BIO Business Forum during the 2008 BIO International Convention to be held in San Diego, California from June 17-20. Dr. Kubota will present at 2:00 p.m. PT on June 17th in room 5A, and will provide the audience with an overview of Acucela and its activities including its recently initiated clinical trial for age-related macular degeneration.
